alfentanil-injection, Alfenta (cont.)
DRUG INTERACTIONS: The doctor should be told of all prescription and nonprescription medications the patient uses, especially of: MAO inhibitors used within the last 2 weeks (e.g., furazolidone, linezolid, phenelzine, procarbazine, selegiline, tranylcypromine), erythromycin, cimetidine. Report the patient's use of drugs that cause drowsiness, such as: sleeping pills, sedatives, tranquilizers, anti-anxiety drugs, other narcotic pain relievers (e.g., codeine), drugs for mood or emotional problems, anti-seizure drugs, muscle relaxants, anti- histamines that cause drowsiness (e.g., diphenhydramine). Additionally, many cough-and-cold medicines contain ingredients that cause drowsiness. Ask the patient if they use any. If needed, consult the pharmacy about the safe use of those products. Other medications should not be started without doctor or pharmacist approval.
OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include: severe trouble breathing (e.g., slow, labored breathing), very low blood pressure.
NOTES: Laboratory and/or medical tests will be performed to monitor the patient's progress.
MISSED DOSE: Not applicable.
STORAGE: Store at room temperature between 59 and 77 degrees F (15 to 25 degrees C) away from light and moisture.
Last Editorial Review: 3/2/2005
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index